首页> 外文OA文献 >Evolution and treatment of vitamin B12 deficiency as a risk factor for (cognitive and functional) neurodegenerative diseases in institutionalized elderly = Evolución y tratamiento de la deficiencia de vitamina B12 como factor de riesgo de enfermedades neurodegenerativas (cognitivas y funcionales) en las personas mayores institucionalizadas.
【2h】

Evolution and treatment of vitamin B12 deficiency as a risk factor for (cognitive and functional) neurodegenerative diseases in institutionalized elderly = Evolución y tratamiento de la deficiencia de vitamina B12 como factor de riesgo de enfermedades neurodegenerativas (cognitivas y funcionales) en las personas mayores institucionalizadas.

机译:维生素B12缺乏症的发展和治疗,作为制度化老年人(认知和功能性)神经退行性疾病的危险因素=维生素B12缺乏症的发展和治疗,作为制度化老年人中神经退行性疾病(认知和功能性)的危险因素。

摘要

Prevalence of vitamin B12 deficiency is very common in elderly people and can reach values as high as 40.5% of the population. It can be the result of the interaction among several factors. Vitamin B12 deficiencies have been associated with neurological, cognitive deterioration, haematological abnormalities and cardiovascular diseases that have an important influence on the health of the elderly and their quality of life. It is necessary to approach the problems arisen from the lack of data relative to them. The main objective of this thesis was to analyse the evolution of vitamin B12 status and related parameters, lipid and haematological profiles and their relationship to health risk factors, and to functional and cognitive status over one year and to determine the effect of an oral supplementation of 500 μg of cyanocobalamin for a short period of 28 days. An additional objective was to analyze the possible effects of medicine intakes on vitamin B status. Three studies were performed: a) a one year longitudinal follow-up with four measure points; b) an intervention study providing an oral liquid supplement of 500 μg of cyanocobalamin for a 28 days period; and c) analysis of the possible effect of medication intake on vitamin B status using the ATC classification of medicines. The participants for these studies were recruited from nursing homes for the elderly in the Region of Madrid. Sixty elders (mean age 84 _ 7y, 19 men and 41 women) were recruited for Study I and 64 elders (mean age 82 _ 7y, 24 men and 40 women) for Study II. For Study III, baseline data from the initially recruited participants of the first two studies were used. An informed consent was obtained from all participants or their mentors. The studies were approved by the Ethical Committee of the University of Granada. Blood samples were obtained at each examination date and were analyzed for serum cobalamin, holoTC, serum and RBC folate and total homocysteine according to laboratory standard procedures. The haematological parameters analyzed were haematocrit, haemoglobin and MCV. For the lipid profile TG, total cholesterol, LDL- and HDLcholesterol were analyzed. Anthropometric measures (BMI, skinfolds [triceps and subscapular], waist girth and waist to hip ratio), functional tests (hand grip, arm and leg strength tests, static balance) and MMSE were obtained or administered by trained personal. The vitamin B12 supplement of Study II was administered with breakfast and the medication intake was taken from the residents’ anamnesis. Data were analyzed by parametric and non-parametric statistics depending on the obtained data. Comparisons were done using the appropriate ANOVAs or non-parametric tests. Pearsons’ partial correlations with the variable “time” as control were used to define the association of the analyzed parameters. XIII The results showed that: A) Over one year, in relationship to vitamin B status, serum cobalamin decreased, serum folate and mean corpuscular volumen increased significantly and total homocysteine concentrations were stable. Regarding blood lipid profile, triglycerides increased and HDL-cholesterol decreased significantly. Regarding selected anthropometric measurements, waist circumference increased significantly. No significant changes were observed for the rest of parameters. B) Prevalence of hyperhomocysteinemia was high in the elderly studied, ranging from 60% to 90 % over the year depending on the cut-off used for the classification. LDL-cholesterol values were high, especially among women, and showed a tendency to increase over the year. Results of the balance test showed a deficiency and a tendency to decrease; this indicates that the population studied is at high risk for falls. Lower extremity muscular function was deficient and showed a tendency to decrease. A highly significant relationship was observed between the skinfold of the triceps and blood lipid profile. C) Low cobalamin concentrations correlated significantly with low MMSE scores in the elderly studied. No correlations were observed between vitamin B12 status and functional parameters. D) Regarding vitamin B12 status, holo-transcobalamin seems to be more sensitive for diagnosis; 5-10% of the elderly had a deficiency using serum cobalamin as a criterion, and 45-52% had a deficiency when using serum holotranscobalamin as a criterion. E) 500 μg of cyanocobalamin administered orally during 28 days significantly improved vitamin B12 status and significantly decreased total homocysteine concentrations in institutionalized elderly. No effect of the intervention was observed on functional and cognitive parameters. F) The relative change (%) of improvement of vitamin B12 status was higher when using serum holo-transcobalamin as a criterion than serum cobalamin. G) Antiaenemic drug intake normalized cobalamin, urologic drugs and corticosteroids serum folate, and psychoanaleptics holo-transcobalamin levels. Drugs treating pulmonary obstruction increased total homocysteine concentration significantly. H) The daily mean drug intake was 5.1. Fiftynine percent of the elderly took medication belonging to 5 or more different ATC groups. The most prevalent were psycholeptic (53%), antiacid (53%) and antithrombotic (47%) drugs.
机译:维生素B12缺乏症的患病率在老年人中非常普遍,可以达到人口总值的40.5%。这可能是几个因素之间相互作用的结果。维生素B12缺乏症与神经系统疾病,认知能力下降,血液学异常和心血管疾病有关,对老年人的健康及其生活质量具有重要影响。有必要解决由于缺乏与之相关的数据而引起的问题。本论文的主要目的是分析维生素B12状态及其相关参数,脂质和血液学特征及其与健康危险因素,功能和认知状态的关系在一年内的演变,并确定口服补充维生素B12的效果。 500μg氰钴胺素在短短28天之内。另一个目标是分析药物摄入对维生素B状态的可能影响。进行了三项研究:a)一年的纵向随访,包括四个测量点; b)一项干预研究,在28天内提供了500μg氰钴胺的口服液体补充剂; c)使用ATC药物分类分析药物摄入对维生素B状况的可能影响。这些研究的参与者是从马德里地区的老人护理院招募的。研究I招募了60名老年人(平均年龄84到7y,男19名,女性41名),研究II招募了64名老年人(平均年龄82到7y,男24名,女性40名)。对于研究III,使用了前两项研究最初招募的参与者的基线数据。已从所有参与者或其导师处获得了知情同意。研究得到格拉纳达大学伦理委员会的批准。在每个检查日期获取血样,并根据实验室标准程序分析血清中的钴胺素,holoTC,血清和RBC叶酸以及总高半胱氨酸。分析的血液学参数是血细胞比容,血红蛋白和MCV。对于TG的脂质概况,分析了总胆固醇,LDL-和HDL胆固醇。人体测量指标(BMI,皮褶[肱三头肌和肩cap下],腰围和腰臀比),功能测试(手握力,手臂和腿部力量测试,静态平衡)和MMSE由受过训练的人员获得或进行。研究II的维生素B12补充剂与早餐一起服用,药物的摄取来自居民的回忆。根据获得的数据,通过参数和非参数统计分析数据。使用适当的方差分析或非参数检验进行比较。皮尔逊(Pearsons)与变量“时间”作为控制的部分相关性用于定义分析参数的关联。 XIII结果显示:A)一年以上,与维生素B状态相关,血清钴胺素减少,血清叶酸和平均红细胞体积显着增加,总半胱氨酸浓度稳定。在血脂方面,甘油三酸酯升高,HDL-胆固醇显着降低。关于人体测量,腰围明显增加。其余参数未观察到显着变化。 B)在所研究的老年人中,高同型半胱氨酸血症的患病率较高,取决于分类的临界值,一年中高同型半胱氨酸血症的患病率从60%到90%不等。 LDL-胆固醇值很高,尤其是在女性中,并且呈逐年上升的趋势。平衡测试的结果表明缺乏,并有降低的趋势。这表明所研究的人群有跌倒的高风险。下肢肌肉功能不足,呈下降趋势。肱三头肌的皮褶与血脂水平之间存在高度显着的关系。 C)在研究的老年人中,低钴胺素浓度与低MMSE得分显着相关。维生素B12状态与功能参数之间没有相关性。 D)关于维生素B12的状况,全反式钴胺素似乎对诊断更为敏感;以血清钴胺素为标准的老年人中有5-10%缺乏,以血清全反钴胺素为标准的老年人中有45-52%有缺乏。 E)在28天内口服500μg氰钴胺素可以显着改善维生素B12的状况,并显着降低住院老人的总同型半胱氨酸浓度。没有观察到干预对功能和认知参数的影响。 F)当使用血清全反式钴胺素作为标准时,维生素B12状态改善的相对变化(%)高于血清钴胺素。 G)降血脂药物摄入标准化钴胺素,泌尿科药物和皮质类固醇的血清叶酸,和精神科医师的全反钴胺素水平。治疗肺阻塞的药物可显着增加总同型半胱氨酸浓度。 H)每日平均药物摄入量为5.1。 50%的老年人服用了属于5个或更多不同ATC组的药物。最流行的是精神抑制药(53%),抗酸药(53%)和抗血栓药(47%)。

著录项

  • 作者

    Albers Ulrike;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号